Docetaxel and cisplatin in patients with advanced gastric cancer: results of Japanese phase I/II study

被引：1

作者：

Soh Saitoh

Yuh Sakata

机构：

[1] Aomori Prefectural Central Hospital,

[2] Misawa Municipal Hospital,undefined

来源：

Gastric Cancer | 2002年 / 5卷 / Suppl 1期

关键词：

Docetaxel; Cisplatin; Gastric cancer;

D O I：

10.1007/s10120-002-0209-0

中图分类号：

学科分类号：

摘要：

Two phase II monotherapy studies of docetaxel in patients with advanced gastric cancer were performed in Japan. In group A, docetaxel showed an overall response rate of 23.7% (14/59) in 59 patients, and the adverse reactions were tolerable. In group B, this agent showed the same response rate, of 23.7% (14/59) and the same adverse reaction profile.

引用

页码：23 / 26

页数：3

共 50 条

[41] Phase II study of biweekly docetaxel and cisplatin combination chemotherapy in first-line advanced gastric cancer
Quintero, G., Sr.
Jorge, M.
Casal, J.
Salgado, M.
Candamio, S.
Lopez, R.
Mel, J. R.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[42] Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer
G. Quintero-Aldana
M. Jorge
C. Grande
M. Salgado
E. Gallardo
S. Varela
C. López
M. J. Villanueva
A. Fernández
E. Alvarez
P. González
J. Castellanos
J. Casal
R. López
B. Campos Balea
Cancer Chemotherapy and Pharmacology, 2015, 76 : 731 - 737
[43] Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer
Quintero-Aldana, G.
Jorge, M.
Grande, C.
Salgado, M.
Gallardo, E.
Varela, S.
Lopez, C.
Villanueva, M. J.
Fernandez, A.
Alvarez, E.
Gonzalez, P.
Castellanos, J.
Casal, J.
Lopez, R.
Campos Balea, B.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (04) : 731 - 737
[44] A phase I/II study of S-1 plus cisplatin alternating with S-1 plus docetaxel in patients with advanced gastric cancer (AGC)
Hosokawa, A.
Ogawa, K.
Kajiura, S.
Tsukioka, Y.
Kobayashi, T.
Horikawa, N.
Kobayashi, Y.
Yoshioka, A.
Sumi, S.
Sugiyama, T.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
[45] Phase I study of imatinib, cisplatin, and fluoruracil in patients with advanced gastric cancer.
Mayr, Martina
Alberter, Barbara
Becker, Karin
Schmid, Roland M.
Ebert, Matthias Philip
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
[46] Phase I/II study of docetaxel (DOC) and S-1 for patients (pts) with advanced gastric cancer (AGC).
Hyodo, I
Yamaguchi, K
Koizumi, W
Narahara, H
Kato, T
Akiya, T
Sakata, Y
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 323S - 323S
[47] A randomized phase II trial of weekly docetaxel plus either cisplatin or oxaliplatin in patients with previously untreated advanced gastric cancer: Preliminary results
Sym, S.
Park, S.
Park, J.
Kwon, K.
Jung, I.
Cho, E.
Lee, W.
Chung, M.
Shin, D.
Lee, J.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[48] Updated results of a randomized phase II trial for neoadjuvant versus adjuvant docetaxel/cisplatin chemotherapy in patients with locally advanced gastric cancer.
Kim, Young Woo
Ryu, Keun Won
Choi, Il Ju
Kook, Myeong-Cherl
Park, Young Iee
Kim, Hark K.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
[49] A randomized phase II trial of weekly docetaxel plus either cisplatin or oxaliplatin in patients with previously untreated advanced gastric cancer: Preliminary results
Sym, S.
Park, S.
Park, J.
Park, Y.
Jung, I.
Cho, E.
Lee, W.
Chung, M.
Shin, D.
Lee, J.
EJC SUPPLEMENTS, 2009, 7 (02): : 383 - 383
[50] Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors
Pronk, LC
Schellens, JHM
Planting, AST
vandenBent, MJ
Hilkens, PHE
vanderBurg, MEL
deBoerDennert, M
Ma, J
Blanc, C
Harteveld, M
Bruno, R
Stoter, G
Verweij, J
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1071 - 1079

← 1 2 3 4 5 →